Free Shipping on orders of $150 or more!
An evidence-based look at research and potential supportive roles (not medical advice)
Chemotherapy can cause a range of side effects that significantly affect quality of life, including nausea, vomiting, pain, sleep disruption, and anxiety. Researchers have long been interested in whether components of the cannabis plant—including cannabidiol (CBD), a non-intoxicating compound—may play a role in alleviating some of these symptoms when used in a supportive context. (Healthline, University of Texas)
Although many studies involve combinations of cannabinoids or formulations involving THC and CBD together, a few key findings from clinical and scientific literature provide useful context:
Cannabinoids have been studied for their effects on chemotherapy-induced nausea and vomiting (CINV). Some clinical trials involving cannabis extracts with both THC and CBD have shown modest reductions in nausea scores compared to placebo when used alongside standard antiemetic medications. (PubMed)
Some systematic reviews suggest that cannabinoids in general may be associated with reduced pain and anxiety in people undergoing cancer therapy. These analyses include many studies with various cannabinoid formulations and note trends toward improvement in symptoms like pain, nausea, and sleep disturbance—while also highlighting limitations in study quality and consistency. (PubMed)
CBD itself has been shown in laboratory and preclinical studies to interact with the body’s endocannabinoid system and inflammatory pathways, which are involved in pain and immune responses. This has led to interest in CBD’s potential role in supporting comfort and reducing inflammatory signaling, though more clinical research is needed to understand how this translates to human chemotherapy experiences. (MDPI)
Sleep disruption and anxiety are common challenges for people undergoing chemotherapy. Some evidence suggests cannabinoids may support improved sleep and reduced anxiety symptoms in general populations. While specific clinical studies on CBD during chemotherapy are limited, these general findings provide context for why some patients explore CBD as part of an integrative wellness approach. (PubMed, Healthline)
It’s important to stress that CBD is not an FDA-approved treatment for cancer or chemotherapy side effects and should not be used as a substitute for prescribed antiemetic or supportive care medications. (University of Texas)
That said, emerging research and clinical observations have spurred interest in CBD as part of a broader supportive care strategy, especially because CBD is non-intoxicating and is generally well-tolerated in many individuals when used responsibly. Any consideration of CBD alongside cancer treatment should be discussed with a healthcare provider to account for potential interactions with other medications and individual health factors.
Personalized guidance—especially from clinicians with expertise in pharmacology and botanical medicine—can help individuals and caregivers explore whether CBD fits into a supportive plan that aligns with their overall goals and medical care. At Hempeutics, consultations aim to provide education and individualized guidance rather than making clinical claims about outcomes.
If you’re curious about exploring supportive options and how they may integrate with your care, you can start by filling out the intake form here or at Hempeutics.com to schedule a personalized consultation.
Book your free 20-minute consultation with Dr. Peggy to discuss your health goals and receive a custom clinical-grade CBD plan.